Your account is not claimed yet. You can sign up with ORCID to claim your account.

Julio Delgado (J Delgado)

Loop profile ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 23

Top Venues

British journal of haematology

Leukemia

Blood

The oncologist

Hospital Clínic de Barcelona

Universitat Pompeu Fabra (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Clínic de Barcelona Dec 15o 2010

Spain

Consultant :: Haematology

Education History

Universitat Pompeu Fabra

Spain

MSC :: Barcelona School of Management

Publications

Ana Belen Moreno-Castaño, Sara Fernández, Helena Ventosa, Marta Palomo, Julia Martinez-Sanchez, Alex Ramos, Valentín Ortiz-Maldonado, Julio Delgado, Carlos Fernández de Larrea, Alvaro Urbano-Ispizua, Olaf Penack, J M Nicolás, Adrian Téllez, Gines Escolar, Enric Carreras, Francesc Fernández-Avilés, Pedro Castro, Maribel Diaz-Ricart
Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis. Journal for immunotherapy of cancer 11 (4) (2023)
Kai Rejeski, Marion Subklewe, Mahmoud Aljurf, Emmanuel Bachy, Adriana Cristina Balduzzi, Pere Barba, Benedetto Bruno, Reuben Benjamin, Matteo Giovanni Giovanni Carrabba, Christian Chabanon, Fabio Ciceri, Paolo Corradini, Julio Delgado, Roberta Di Blasi, Raffaella Greco, Roch Houot, Gloria Iacoboni, Ulrich Jäger, Marie José Kersten, Stephan Mielke, Arnon Nagler, Francesco Onida, Zinaida Peric, Claire Roddie, Annalisa Ruggeri, Fermin M Sanchez-Guijo, Isabel Sánchez-Ortega, Dominik Schneidawind, Maria-Luisa Schubert, John A Snowden, Catherine Thieblemont, Max S Topp, Pier Luigi Luigi Zinzani, John G Gribben, Chiara Bonini, Anna Sureda Balari, Ibrahim Yakoub Agha
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations. Blood (2023)
Núria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego, Andrea Blázquez, Joan Cid, Miquel Lozano, Laura Magnano, Eva Giné, Juan G Correa, Pablo Mozas, Luis Gerardo Rodríguez-Lobato, Andrea Rivero, Mercedes Montoro-Lorite, Pilar Ayora, Sergio Navarro, Leticia Alserawan, E Azucena González-Navarro, Maria Castellà, María Sánchez-Castañón, Raquel Cabezón, Daniel Benítez-Ribas, Xavier Setoaín, Sonia Rodríguez, Helena Brillembourg, Sara Varea, Eulalia Olesti, Elena Guillén, Joaquín Sáez-Peñataro, Carlos Fernández de Larrea, Armondo López-Guillermo, Mariona Pascal, Álvaro Urbano-Ispizua, Manel Juan, Julio Delgado
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma. British journal of haematology (2023)
Ilaria Del Giudice, Luca Vincenzo Cappelli, Julio Delgado, Carsten Utoft Niemann, Michael Asger Andersen, Emelie Hamotal Curovic Rotbain, Kathrine Aarup, Renata Walewska, Andrea Visentin, Marina Deodato, Anna Maria Frustaci, Chiara Cavalloni, Massimo Gentile, Mohamad A Yassin, Deepesh P Lad, Lydia Scarfò, Max Flogegard, Mattias Mattsson, Sara Raponi, Caterina Ilari, Irene Della Starza, Ester M Orlandi, Alessandra Tedeschi, Livio Trentin, Gianpietro Semenzato, Anna Guarini, Paolo Ghia, Emili Montserrat, Robin Foà
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature. British journal of haematology (2023)
Ferran Nadeu, Charlotte Syrykh, Berta Pons-Brun, Núria Russiñol, Heribert Playa-Albinyana, Tycho Stephan Baumann, Martí Duran-Ferrer, Marta Kulis, Anna Carbó-Meix, Pablo Mozas, Miguel Alcoceba, Marcos González-Díaz, Almudena Navarro-Bailón, Enrique Colado, Ángel Payer, Marta Aymerich, María José Terol, JunYan Lu, Binyamin Asher Knisbacher, Cynthia K Hahn, Sílvia Ruiz-Gaspà, Anna Enjuanes, Catherine J Wu, Gad Getz, Thorsten Zenz, Armando López-Guillermo, José Ignacio Martin-Subero, Dolors Colomer, Julio Delgado, Elias Campo
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia. Blood advances (2023)
C Mircea S Tesileanu, Sotirios Michaleas, Rocio Gonzalo Ruiz, Segundo Mariz, Babs O Fabriek, Paula B van Hennik, Jutta Dedorath, Bruna Dekic, Christoph Unkrig, Andreas Brandt, Janet Koenig, Harald Enzmann, Julio Delgado, Francesco Pignatti
The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With At Least 2 Tyrosine Kinase Inhibitors. The oncologist (2023)
Heribert Playa-Albinyana, Fabian Arenas, Romina Royo, Ariadna Giró, Irene López-Oreja, Marta Aymerich, Mònica López-Guerra, Gerard Frigola, Sílvia Beà, Julio Delgado, Pablo M Garcia-Roves, Elias Campo, Ferran Nadeu, Dolors Colomer
Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation. Leukemia (2023)
Clara Bueno, Susana Barrera, Alex Bataller, Valentín Ortiz-Maldonado, Natalina Elliot, Sorcha O'Byrne, Guanlin Wang, Montse Rovira, Francisco Gutierrez-Agüera, Juan L Trincado, María González-González, Mireia Morgades, Marc Sorigue, Paloma Bárcena, Samanta Romina Zanetti, Montserrat Torrebadell, Nerea Vega-García, Susana Rives, Mar Mallo, Francesc Sole, Adam J Mead, Irene Roberts, Supat Thongjuea, Bethan Psaila, Manel Juan, Julio Delgado, Alvaro Urbano-Ispizúa, Josep-María Ribera, Alberto Orfao, Anindita Roy, Pablo Menendez
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies. Blood 140 (1) (2022)
Valentín Ortiz-Maldonado, Anna Alonso-Saladrigues, Marta Español-Rego, Nuria Martínez-Cibrián, Anna Faura, Laura Magnano, Albert Català, Daniel Benítez-Ribas, Eva Giné, Marina Díaz-Beyá, Juan Gonzalo Correa, Montserrat Rovira, Mercedes Montoro-Lorite, Alexandra Martínez-Roca, Luis Gerardo Rodríguez-Lobato, Raquel Cabezón, Joan Cid, Miquel Lozano, Enric Garcia-Rey, Nuria Conde, Georgina Pedrals, María Rozman, Montserrat Torrebadell, Xavier Setoain, Sonia Rodríguez, Jordi Esteve, Mariona Pascal, Álvaro Urbano-Ispizua, Manel Juan, Julio Delgado, Susana Rives
Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary disease. American journal of hematology 97 (6) (2022)
Valentín Ortiz-Maldonado, Susana Rives, Marta Español-Rego, Anna Alonso-Saladrigues, Mercedes Montoro, Laura Magnano, Eva Giné, Mariona Pascal, Marina Díaz-Beyá, Maria Castella, Albert Català, Anna Faura, Luis Gerardo Rodríguez-Lobato, Marta Garrote, Alexandra Martínez-Roca, Montserrat Rovira, E Azucena González-Navarro, Juan Ramón Ortega, Joan Cid, Miquel Lozano, Enric Garcia-Rey, Sara Fernández, Pedro Castro, Iolanda Jordan, Neus Villamor, Marta Aymerich, Montserrat Torrebadell, Àngela Deyà, Carlos Fernández de Larrea, Daniel Benitez-Ribas, Esteve Trias, Sara Varea, Gonzalo Calvo, Jordi Esteve, Alvaro Urbano-Ispizua, Manel Juan, Julio Delgado
Factors associated with the clinical outcome of patients with relapsed/refractory CD19 + acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy. Journal for immunotherapy of cancer 9 (12) (2022)
Julio Delgado, Filip Josephson, Jorge Camarero, Blanca Garcia-Ochoa, Lucia Lopez-Anglada, Carolina Prieto-Fernandez, Paula B van Hennik, Irene Papadouli, Christian Gisselbrecht, Harald Enzmann, Francesco Pignatti
EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia. The oncologist 26 (3) (2021)
Gabriela Bastidas-Mora, Sílvia Beà, Alba Navarro, Eva Gine, Dolors Costa, Julio Delgado, Tycho Baumann, Laura Magnano, Alfredo Rivas-Delgado, Neus Villamor, Dolors Colomer, Mónica López-Guerra, María Rozman, Olga Balagué, Daniel Martinez, Maria Joao Baptista, Lourdes Escoda, Miguel Alcoceba, Margarita Blanes, Fina Climent, Elias Campo, Andrew Wotherspoon, Armondo López-Guillermo, Estella Matutes
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation. British journal of haematology (2021)
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Ferran Nadeu, Eva Giné, Julio Delgado, Neus Villamor, Elias Campo, Patricia Pérez-Galán, Laura Magnano, Armondo López-Guillermo
The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma. Leukemia & lymphoma (2021)
Julio Delgado, Malgorzata Zienowicz, Paula Boudewina van Hennik, Alexandre Moreau, Christian Gisselbrecht, Harald Enzmann, Francesco Pignatti
EMA Review of Isatuximab in Combination with Pomalidomide and Dexamethasone for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma. The oncologist 26 (11) (2021)
Pablo Mozas, Marc Sorigue, Alfredo Rivas-Delgado, Andrea Rivero, Juan Gonzalo Correa, Carlos Castillo, Ferran Nadeu, Alex Bataller, Eva Giné, Tycho Baumann, Julio Delgado, Neus Villamor, Elias Campo, Laura Magnano, Juan-Manuel Sancho, Armondo López-Guillermo
The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients. European journal of haematology 106 (3) (2020)
Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, Ferran Nadeu, Guillem Clot, Juan Gonzalo Correa, Carlos Castillo, Alex Bataller, Tycho Baumann, Eva Giné, Julio Delgado, Neus Villamor, Elias Campo, Patricia Pérez-Galán, Laura Magnano, Armondo López-Guillermo
A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphoma. Leukemia & lymphoma 62 (1) (2020)
Theodoros Moysiadis, Panagiotis Baliakas, Davide Rossi, Mark Catherwood, Jonathan C Strefford, Julio Delgado, Achilles Anagnostopoulos, Chrysoula Belessi, Niki Stavroyianni, Sarka Pospisilova, David Oscier, Gianluca Gaidano, Elias Campo, Richard Rosenquist, Paolo Ghia, Kostas Stamatopoulos
Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors. Leukemia 33 (7) (2019)
Pablo Mozas, Alfredo Rivas-Delgado, Tycho Baumann, Neus Villamor, Valentín Ortiz-Maldonado, Marta Aymerich, Dolors Costa, Alba Navarro, Eva Giné, Armando López-Guillermo, Emili Montserrat, Julio Delgado
Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia. Blood cancer journal 8 (1) (2018)
Carol Moreno, Julio Delgado, John C Byrd, William L Zvagelsky, Samuel Suzuki, Emily Hsu, Danelle F James, Emili Montserrat
Changes in clinical stage identify patients with CLL and different outcome within iwCLL partial response: RESONATE study. British journal of haematology 185 (1) (2018)
Alfredo Rivas-Delgado, Laura Magnano, Miriam Moreno-Velázquez, Olga García, Ferran Nadeu, Pablo Mozas, Ivan Dlouhy, Tycho Baumann, Jordina Rovira, Blanca González-Farre, Antonio Martínez, Olga Balague, Julio Delgado, Neus Villamor, Eva Giné, Elías Campo, Juan M Sancho-Cia, Armando López-Guillermo
Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era. British journal of haematology 184 (5) (2018)
J R Brown, P Hillmen, S O'Brien, J C Barrientos, N M Reddy, S E Coutre, C S Tam, S P Mulligan, U Jaeger, P M Barr, R R Furman, T J Kipps, F Cymbalista, P Thornton, F Caligaris-Cappio, Julio Delgado, M Montillo, S DeVos, C Moreno, J M Pagel, T Munir, J A Burger, D Chung, J Lin, L Gau, B Chang, G Cole, E Hsu, D F James, J C Byrd
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL. Leukemia 32 (1) (2017)
Valentín Ortiz-Maldonado, Neus Villamor, Tycho Baumann, Marta Aymerich, Laura Magnano, Pablo Mozas, Alfredo Rivas-Delgado, Alejandra Martínez-Trillos, Eva Giné, Elías Campo, Armando López-Guillermo, Julio Delgado
Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia? British journal of haematology 183 (1) (2017)
Alejandra Martínez-Trillos, Alba Navarro, Marta Aymerich, Julio Delgado, Armando López-Guillermo, Elias Campo, Neus Villamor
Clinical impact of MYD88 mutations in chronic lymphocytic leukemia. Blood 127 (12) (2016)

Julio Delgado.css-eqlu8i{font-size:small;padding-left:4px;} (J Delgado)

Publication Activity (10 Years)

Top Topics

Top Venues

Julio Delgado (J Delgado)